Related references
Note: Only part of the references are listed.The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
Stefanie Klenke et al.
BMC CANCER (2019)
BCL-x(L)-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis
Sara Fatima Faqar-Uz-Zaman et al.
CANCER LETTERS (2018)
The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
Raedeh Saraei et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α
Doerte Langemann et al.
ONCOTARGET (2017)
YAP and the Hippo pathway in pediatric cancer
Atif A. Ahmed et al.
MOLECULAR & CELLULAR ONCOLOGY (2017)
Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells
Shufeng Zhang et al.
CANCER INVESTIGATION (2016)
Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells
Steve Gerges et al.
CANCER LETTERS (2016)
Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia
M. Schirmer et al.
CELL DEATH & DISEASE (2016)
XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis
Zhang'e Choo et al.
ONCOTARGET (2016)
Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
Corinne Bouvier et al.
ONCOTARGET (2016)
Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance
Atif A. Ahmed et al.
JOURNAL OF CANCER (2015)
Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation
Tianxin Yang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
Katherine K. Slemmons et al.
PLOS ONE (2015)
Childhood and adolescent cancer statistics, 2014
Elizabeth Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts
Santi Suryani et al.
CLINICAL CANCER RESEARCH (2014)
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future
Lisa M. Sedger et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Expression and prognostic significance of livin/BIRC7 in childhood acute lymphoblastic leukemia
Lamia Ibrahim et al.
MEDICAL ONCOLOGY (2014)
BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Andrew S. Moore et al.
PEDIATRIC BLOOD & CANCER (2014)
RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
Zhi Xiong Chen et al.
CANCER DISCOVERY (2014)
XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
Daniel Moreno-Martinez et al.
ONCOTARGET (2014)
Death receptors as targets in cancer
O. Micheau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Pan-Mammalian Target of Rapamycin (mTOR) Inhibitor AZD8055 Primes Rhabdomyosarcoma Cells for ABT-737-induced Apoptosis by Down-regulating Mcl-1 Protein
Ellen Preuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
BIRC5 Expression Is a Poor Prognostic Marker in Ewing Sarcoma
Pooja Hingorani et al.
PEDIATRIC BLOOD & CANCER (2013)
Involvement of substance P and the NK-1 receptor in cancer progression
Miguel Munoz et al.
PEPTIDES (2013)
Mechanisms of Action of Bcl-2 Family Proteins
Aisha Shamas-Din et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
The Bcl-2/Bax and Ras/Raf/MEK/ERK signaling pathways: implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches
Orsola Vitagliano et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma
Kelly C. Goldsmith et al.
CANCER RESEARCH (2012)
Smac Mimetic LBW242 Sensitizes XIAP-Overexpressing Neuroblastoma Cells for TNF-α-Independent Apoptosis
Georg Eschenburg et al.
CANCER RESEARCH (2012)
BIRC6/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis
Eman Abdel Rahman Ismail et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies
Haibo Bai et al.
HUMAN PATHOLOGY (2012)
Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors
Melinda S. Merchant et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis
S. Loeder et al.
LEUKEMIA (2012)
Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study
Na Tong et al.
LEUKEMIA & LYMPHOMA (2012)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2012)
Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells
Aiguo Liu et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma
Hua Fang et al.
CLINICAL CANCER RESEARCH (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis
A. Bender et al.
ONCOGENE (2011)
Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents
Sarah V. Holt et al.
ONCOLOGY REPORTS (2011)
Hedgehog Pathway Activity in Pediatric Embryonal Rhabdomyosarcoma and Undifferentiated Sarcoma: A Report From the Children's Oncology Group
Joseph G. Pressey et al.
PEDIATRIC BLOOD & CANCER (2011)
Sensitization of Osteosarcoma Cell Line SaOS-2 to Chemotherapy by Downregulating Survivin
Jun Zou et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Hedgehog beyond medulloblastoma and basal cell carcinoma
Stephan Teglund et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists
K. C. Goldsmith et al.
CELL DEATH AND DIFFERENTIATION (2010)
Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosis
Sandra Loeder et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Increased expression of the hedgehog signaling pathway in pediatric solid malignancies
Takaharu Oue et al.
JOURNAL OF PEDIATRIC SURGERY (2010)
The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs
Laura M. High et al.
MOLECULAR PHARMACOLOGY (2010)
Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients
Agnieszka Pluta et al.
LEUKEMIA RESEARCH (2010)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2
Hao Zhang et al.
ONCOLOGY REPORTS (2010)
Initial Testing (Stage 1) of Mapatumumab (HGS-ETR1) by the Pediatric Preclinical Testing Program
Malcolm A. Smith et al.
PEDIATRIC BLOOD & CANCER (2010)
XIAP Expression Is Post-Transcriptionally Upregulated in Childhood ALL and Is Associated With Glucocorticoid Response in T-Cell ALL
Patrick Hundsdoerfer et al.
PEDIATRIC BLOOD & CANCER (2010)
Smac mimetics as new cancer therapeutics
Derrick J. Chen et al.
ANTI-CANCER DRUGS (2009)
Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance
Melanie Fakler et al.
BLOOD (2009)
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists
Brian J. Lestini et al.
CANCER BIOLOGY & THERAPY (2009)
Blocking the Hedgehog Pathway Inhibits Hepatoblastoma Growth
Melanie Eichenmueller et al.
HEPATOLOGY (2009)
The Many Roles of FAS Receptor Signaling in the Immune System
Andreas Strasser et al.
IMMUNITY (2009)
Following TRAIL's path in the immune system
Christina Falschlehner et al.
IMMUNOLOGY (2009)
Survivin minigene DNA vaccination is effective against neuroblastoma
Stefan Fest et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum
Susanne Schlisio
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia
Aaron D. Schimmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overexpression of X-linked Inhibitor of Apoptosis Protein (XIAP) is an Independent Unfavorable Prognostic Factor in Childhood de Novo Acute Myeloid Leukemia
Ki Woong Sung et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Inhibitor of apoptosis proteins and apoptosis
Yunbo Wei et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2008)
Notch signaling in leukemia
Jon C. Aster et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Bcl-2 family members as molecular targets in cancer therapy
Isabel Marzo et al.
BIOCHEMICAL PHARMACOLOGY (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
The mitochondrial serine protease HtrA2/Omi: an overview
L. Vande Walle et al.
CELL DEATH AND DIFFERENTIATION (2008)
被撤回的出版物: Critical role of Notch signaling in osteosarcoma invasion and metastasis (Retracted article. See vol. 19, pg. 5256, 2013)
Pingyu Zhang et al.
CLINICAL CANCER RESEARCH (2008)
To kill a tumor cell: the potential of proapoptotic receptor agonists
Avi Ashkenazi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines:: Mcl-1 inactivation
Min H. Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program
Richard Lock et al.
PEDIATRIC BLOOD & CANCER (2008)
Notch Signaling in Pediatric Malignancies
Patrick A. Zweidler-McKay
CURRENT ONCOLOGY REPORTS (2008)
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia
Victoria Del Gaizo Moore et al.
BLOOD (2008)
Livin and Bcl-2 expression in high-grade osteosarcoma
T. Nedelcu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo
Min H. Kang et al.
BLOOD (2007)
Degradation of survivin by the x-linked inhibitor of apoptosis (XIAP)-XAF1 complex
Vinay Arora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Overexpression of apollon, an antiapoptotic protein, is associated with poor prognosis in childhood De novo acute myeloid leukemia
Ki Woong Sung et al.
CLINICAL CANCER RESEARCH (2007)
Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells
Tsuyoshi Shimo et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2007)
Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia
Anja Troeger et al.
HAEMATOLOGICA (2007)
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737
X. Lin et al.
ONCOGENE (2007)
Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia
A. Troeger et al.
KLINISCHE PADIATRIE (2007)
The apoptosome: signalling platform of cell death
Stefan J. Riedl et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Inhibition of Notch signaling induces neural differentiation in Ewing sarcoma
Frank Baliko et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Phase I trial of g3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: A Children's Oncology Group study
Susan R. Rheingold et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Apoptosome dependent caspase-3 activation pathway is non-redundant and necessary for apoptosis in sympathetic neurons
K. M. Wright et al.
CELL DEATH AND DIFFERENTIATION (2007)
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation
Shuang Chen et al.
CANCER RESEARCH (2007)
Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia
Jaewon Choi et al.
BLOOD (2007)
Hedgehog signaling promotes medulloblastoma survival via Bc/II
Eli E. Bar et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome
Qiwei Yang et al.
CLINICAL CANCER RESEARCH (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Concomitant inhibition of MDM2 and Bcl-2 protein function synergistically induce mitochondrial apoptosis in AML
Kensuke Kojima et al.
CELL CYCLE (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis
Eric C. LaCasse et al.
CLINICAL CANCER RESEARCH (2006)
p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65
Beibei Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: A report from the children's oncology group
Michal A. Miller et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells
Jianghua Lu et al.
FEBS LETTERS (2006)
Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines:: sensitization to cisplatin and doxorubicin
H Ganjavi et al.
CANCER GENE THERAPY (2006)
Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo
H Caldas et al.
JOURNAL OF MEDICAL GENETICS (2006)
Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin
Kerstin Schultze et al.
APOPTOSIS (2006)
Sensitization for γ-irradiation-induced apoptosis by second mitochondria-derived activator of caspase.
S Giagkousiklidis et al.
CANCER RESEARCH (2005)
Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity
M Vogler et al.
ONCOGENE (2005)
Essential role for survivin in early brain development
YY Jiang et al.
JOURNAL OF NEUROSCIENCE (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Significance of survivin mRNA expression in prognosis of neuroblastoma
R Ito et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin
H Ganjavi et al.
CANCER GENE THERAPY (2005)
Role of survivin and its splice variants in tumorigenesis
F Li
BRITISH JOURNAL OF CANCER (2005)
Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: A study of 54 patients
PM Ganigi et al.
PEDIATRIC NEUROSURGERY (2005)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas
S Kim et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
The role of Bcl-2 family members in tumorigenesis
V Kirkin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1
RLH Bigelow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis
Z Xing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de Novo acute myeloid leukemia
I Tamm et al.
CLINICAL CANCER RESEARCH (2004)
Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential
T Hotta et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2003)
The Wnt signaling pathway in solid childhood tumors
R Koesters et al.
CANCER LETTERS (2003)
Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma
XH Yang et al.
CANCER LETTERS (2003)
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB
H Ehrhardt et al.
ONCOGENE (2003)
Transcriptional profiling of the Sonic hedgehog response: A critical role for N-myc in proliferation of neuronal precursors
TG Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Survivin expression in human osteosarcoma is a marker for survival
K Trieb et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)
G Del Poeta et al.
BLOOD (2003)
CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants
CM Wood et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Survivin: Role in Normal Cells and in Pathological Conditions
L. O'Driscoll et al.
CURRENT CANCER DRUG TARGETS (2003)
Clustering of hypermethylated genes in neuroblastoma
MM van Noesel et al.
GENES CHROMOSOMES & CANCER (2003)
Selective chemosensitization of rhabdomyosarcoma cell lines following wild-type p53 adenoviral transduction
S Shetty et al.
ANTI-CANCER DRUGS (2002)
The molecular and genetic basis of neurological tumours
YA Zhu et al.
NATURE REVIEWS CANCER (2002)
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
S Fulda et al.
NATURE MEDICINE (2002)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
S Fulda et al.
ONCOGENE (2002)
The origin of CD95-gene mutations in B-cell lymphoma
M Müschen et al.
TRENDS IN IMMUNOLOGY (2002)
Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways
SL Shankar et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma
T Azuhata et al.
JOURNAL OF PEDIATRIC SURGERY (2001)
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer
S Fulda et al.
ONCOGENE (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis
HU Kontny et al.
CELL DEATH AND DIFFERENTIATION (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
The Survivin : Fas ratio in pediatric renal tumors
S Takamizawa et al.
JOURNAL OF PEDIATRIC SURGERY (2001)
Cellular responses to DNA damage
CJ Norbury et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex
KA DeFea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR
CM Margue et al.
ONCOGENE (2000)
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
H Walczak et al.
EXPERIMENTAL CELL RESEARCH (2000)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
A Islam et al.
ONCOGENE (2000)
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
A Prokop et al.
LEUKEMIA (2000)
Share Paper
